Bed Bath & Beyond Inc. (BBBY) — Earnings Call X-Ray
Our AI read all 29 of BBBY's earnings calls (2016–2023) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
F
Q2 2022
Calls Analyzed
29
2016–2023
Avg Candor
6.2/9
evasion 4.3/9
Call-by-call analysis
🔒 Q3 2022 earnings call
2023-01-10
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q3 2022 call grade is ready
The full 37-point AI read of BBBY's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
F
Q2 2022 earnings call
2022-09-29
Management held guidance steady against slowing demand and contracting margins. The delivery was visibly under pressure.
Guidance: maintainedDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 6 analysts · 6 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q1 2022 earnings call
2022-06-29
Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, visibly under pressure.
Guidance: loweredDemand: slowingMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 7 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hangingCFO dominates
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
F
Q4 2021 earnings call
2022-04-13
Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics, visibly under pressure.
Guidance: loweredDemand: slowingMargins: contractingPricing: raisingHeadcount: cuttingCapex: increasing 8 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
D
Q3 2021 earnings call
2022-01-06
Management lowered guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.
Guidance: loweredDemand: slowingMargins: expandingPricing: raisingCapex: flat 14 analysts · 15 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q2 2021 earnings call
2021-09-30
Management lowered guidance against slowing demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: loweredDemand: slowingMargins: contractingPricing: raisingCapex: flat 12 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growthHidden segmentDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
B
Q1 2021 earnings call
2021-06-30
Management raised guidance against steady demand and expanding margins. The delivery was rich in specifics, promotional in tone.
Guidance: raisedDemand: stableMargins: expandingPricing: stableCapex: increasing 13 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
C+
Q4 2020 earnings call
2021-04-14
Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics, promotional in tone.
Guidance: maintainedDemand: acceleratingMargins: expandingPricing: stableCapex: increasing 13 analysts · 19 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q3 2020 |
2021-01-07 |
B |
raised | mixed | expanding |
6/9 |
3/9 |
| Q2 2020 |
2020-10-01 |
C |
none | accelerating | expanding |
6/9 |
4/9 |
| Q1 2020 |
2020-07-09 |
F |
withdrawn | accelerating | contracting |
7/9 |
5/9 |
| Q4 2019 |
2020-04-15 |
F |
withdrawn | mixed | contracting |
7/9 |
6/9 |
| Q3 2019 |
2020-01-08 |
F |
withdrawn | slowing | contracting |
7/9 |
6/9 |
| Q2 2019 |
2019-10-02 |
F |
maintained | slowing | expanding |
6/9 |
4/9 |
| Q1 2019 |
2019-07-10 |
D |
maintained | slowing | contracting |
7/9 |
4/9 |
| Q4 2018 |
2019-04-10 |
F |
maintained | slowing | contracting |
4/9 |
6/9 |
| Q3 2018 |
2019-01-10 |
F |
raised | slowing | contracting |
6/9 |
5/9 |
| Q2 2018 |
2018-09-27 |
F |
lowered | mixed | contracting |
6/9 |
5/9 |
| Q1 2018 |
2018-06-28 |
D |
maintained | mixed | contracting |
6/9 |
4/9 |
| Q4 2017 |
2018-04-11 |
F |
maintained | mixed | contracting |
6/9 |
4/9 |
| Q3 2017 |
2017-12-21 |
F |
maintained | mixed | contracting |
5/9 |
4/9 |
| Q2 2017 |
2017-09-19 |
F |
lowered | slowing | contracting |
7/9 |
5/9 |
| Q1 2017 |
2017-06-23 |
F |
maintained | slowing | contracting |
7/9 |
5/9 |
| Q4 2016 |
2017-04-06 |
F |
lowered | mixed | contracting |
6/9 |
4/9 |
| Q3 2016 |
2016-12-22 |
F |
lowered | mixed | contracting |
6/9 |
4/9 |
| Q2 2016 |
2016-09-22 |
D |
maintained | slowing | contracting |
6/9 |
4/9 |
| Q1 2016 |
2016-06-22 |
F |
lowered | slowing | contracting |
6/9 |
4/9 |
| Q4 2015 |
2016-04-06 |
C |
maintained | stable | contracting |
6/9 |
3/9 |
| Q3 2015 |
2016-01-07 |
D |
maintained | mixed | contracting |
6/9 |
3/9 |
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← BBAVF All “B” companies
BBCN →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.